Neuroendocrine Differentiation in Prostate Cancer: Implications for New Treatment Modalities
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1998) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.48.1.6 · Cited by 2,341
Somatostatin and Its Receptor Family
Patel, Y. C. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0183 · Cited by 1,648
McDonnell, T. J., Troncoso, P., Brisbay, S. M., Logothetis, C. J., Chung, L. W. K., Hsieh, J., Tu, S., & Campbell, M. L. (1992) · PubMed · Cited by 1,049
The Endocrinology and Developmental Biology of the Prostate*
CUNHA, G. R., DONJACOUR, A. A., COOKE, P. S., MEE, H., BIGSBY, R. M., HIGGINS, S. J., & SUGIMURA, Y. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-3-338 · Cited by 1,036
Veldscholte, J., Ris-Stalpers, C., Kuiper, G. G. J. M., Jenster, G., Berrevoets, C., Claassen, E., van Rooij, H. C. J., Trapman, J., Brinkmann, A. O., & Mulder, E. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80067-1 · Cited by 950
Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938
Bonkhoff, H., & Remberger, K. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199602)28:2<98::aid-pros4>3.0.co;2-j · Cited by 416
Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
Scher, H. I., & Kelly, W. K. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1566 · Cited by 405
Di Sant'Agnese, P. A. (1992) · Cancer · doi:10.1002/1097-0142(19920701)70:1+<254::aid-cncr2820701312>3.0.co;2-e · Cited by 387
Ueda, T., Bruchovsky, N., & Sadar, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108255200 · Cited by 381
Neuroendocrine differentiation in prostatic carcinoma
Abrahamsson, P.-A. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990501)39:2<135::aid-pros9>3.0.co;2-s · Cited by 370
Self-citationRegulation of prostatic growth and function by peptide growth factors
Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Hittmair, A., Zhang, J., Thurnher, M., Bartsch, G., & Klocker, H. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199606)28:6<392::aid-pros9>3.0.co;2-c · Cited by 307
Neuroendocrine cells in tumour growth of the prostate.
Abrahamsson, P. A. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060503 · Cited by 247
Self-citationMyc confers androgen-independent prostate cancer cell growth
Bernard, D., Pourtier, A., Gil, J., & Beach, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19035 · Cited by 224
Arnold, J. T., & Isaacs, J. T. (2002) · Endocrine-related cancer · doi:10.1677/erc.0.0090061 · Cited by 214
Aprikian, A. G., Cardon‐Cardo, C., Fair, W. R., & Reuter, V. E. (1993) · Cancer · doi:10.1002/1097-0142(19930615)71:12<3952::aid-cncr2820711226>3.0.co;2-x · Cited by 207
The role of androgens and the androgen receptor in prostate cancer.
Debes, J. D., & Tindall, D. J. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00413-5 · Cited by 191
Deeble, P. D., Murphy, D. J., Parsons, S. J., & Cox, M. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8471-8482.2001 · Cited by 185
National Cancer Institute roundtable on prostate cancer: future research directions.
Chiarodo, A. (1991) · PubMed · Cited by 166
Elevated Plasma Chromogranin-A Concentrations in Prostatic Carcinoma
Kadmon, D., Thompson, T. C., Lynch, G. R., & Scardino, P. T. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)37793-5 · Cited by 165
Do neuroendocrine cells in human prostate cancer express androgen receptor?
Krijnen, J. L. M., Janssen, P. J. A., de Winter, J. A. R., van Krimpen, H., Schröder, F. H., & van der Kwast, T. (1993) · Histochemistry and Cell Biology · doi:10.1007/bf00268938 · Cited by 155
Dizeyi, N., Bjartell, A., Nilsson, E., Hansson, J., Gadaleanu, V., Cross, N., & Abrahamsson, P. ‐. (2004) · The Prostate · doi:10.1002/pros.10374 · Cited by 154
Self-citationNeuroendocrine Differentiation in Prostatic Carcinoma During Hormonal Treatment
Jiborn, T., Bjartell, A., & Abrahamsson, P.-A. (1998) · Urology · doi:10.1016/s0090-4295(97)00684-5 · Cited by 149
Self-citationLevine, L., Lucci, J. A., Pazdrak, B., Cheng, J. Z., Guo, Y., Townsend, C. M., & Hellmich, M. R. (2003) · PubMed · Cited by 122
Angelsen, A., Syversen, U., Haugen, O. A., Stridsberg, M., Mjølnerød, O. K., & Waldum, H. L. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970101)30:1<1::aid-pros1>3.0.co;2-t · Cited by 121
Angiogenesis, p53, bcl-2 and Ki-67 in the Progression of Prostate Cancer after Radical Prostatectomy
Moul, J. W. (1999) · European Urology · doi:10.1159/000019916 · Cited by 116
Plasma Neuroendocrine Markers in Patients with Benign Prostatic Hyperplasia and Prostatic Carcinoma
Cussenot, O., Villette, J. M., Valéri, A., Cariou, G., Desgrandchamps, F., Cortesse, A., MERIA, P., Teillac, P., Fiet, J., & Duc, A. L. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)66261-x · Cited by 98
Isshiki, S., Akakura, K., Komiya, A., Suzuki, H., Kamiya, N., & Itô, H. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(01)69075-x · Cited by 98
Neuroendocrine pathogenesis in adenocarcinoma of the prostate
Hansson, J., & Abrahamsson, P. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s145 · Cited by 92
Self-citationThe androgen receptor status of neuroendocrine cells in human benign and malignant prostatic tissue.
Nakada, S., di Sant'Agnese, P. A., Moynes, R., Hiipakka, R. A., Liao, S., Cockett, A. T. �., & Abrahamsson, P. (1993) · PubMed · Cited by 87
Self-citationMolecular advances in prostate cancer
Dong, J., Isaacs, W. B., & Isaacs, J. T. (1997) · Current Opinion in Oncology · doi:10.1097/00001622-199701000-00016 · Cited by 87
Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonists.
Abdul, M., Anezinis, P., Logothetis, C. J., & Hoosein, N. M. (1994) · PubMed · Cited by 76
Neuroendocrine Differentiation in Prostatic Carcinoma
Hansson, J., & Abrahamsson, P. (2003) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/03008880310006922 · Cited by 67
Self-citationHansson, J., Bjartell, A. S., Gadaleanu, V., Dizeyi, N., & Abrahamsson, P.-A. (2002) · The Prostate · doi:10.1002/pros.10121 · Cited by 65
Self-citationWang, Q.-C., Horiatis, D., & Pinski, J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20286 · Cited by 62
Jongsma, J., Oomen, M. H. A., Noordzij, M. A., van Weerden, W. M., Martens, G. J. M., van der Kwast, T., Schröder, F. H., & van Steenbrugge, G. J. (2000) · PubMed · Cited by 60
Adam, R. M., Kim, J., Lin, J., Orsola, A., Zhuang, L., Rice, D. C., & Freeman, M. R. (2002) · Endocrinology · doi:10.1210/en.2002-220561 · Cited by 58
Androgen receptor alterations in prostatic carcinoma
Klocker, H., Čulig, Z., Hobisch, A., Cato, A. C. B., & Bartsch, G. H. (1994) · The Prostate · doi:10.1002/pros.2990250506 · Cited by 51
Xie, S., Lin, H., Ni, J., Yang, L., Wang, L., di Sant'Agnese, P. A., & Chang, C. (2004) · The Prostate · doi:10.1002/pros.20048 · Cited by 49
Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer.
Griffiths, K., Ms, M., & Nicholson, R. I. (1997) · PubMed · Cited by 49
Hoosein, N. M., Abdul, M., McCabe, R., Gerö, E., Deftos, L. J., Banks, M., Hodges, S., Finn, L. D., & Logothetis, C. J. (1995) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/1078-1439(96)00012-9 · Cited by 47
Neuroendocrine differentiation of human prostatic primary epithelial cells in vitro
Rumpold, H. F., Heinrich, E., Untergasser, G., Hermann, M., Pfister, G., Plas, E., & Berger, P. (2002) · The Prostate · doi:10.1002/pros.10129 · Cited by 44
Potential clinical value of circulating chromogranin A in patients with prostate carcinoma
Berruti, A., Dogliotti, L., Mosca, A., Gorzegno, G., Bollito, E., Mari, M., Tarabuzzi, R., Poggio, M., TORTA, M., Fontana, D., et al. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s153 · Cited by 40
Serum chromogranin‐A in advanced prostate cancer
Ferrero-Poüs, M., Hersant, A.-M., Pecking, A. P., Brésard‐Leroy, M., & Pichon, M.-F. (2001) · British Journal of Urology · doi:10.1046/j.1464-4096.2001.001223.x · Cited by 38
Medical approaches in the management of prostatic disease
Droller, M. J. (1997) · British Journal of Urology · doi:10.1111/j.1464-410x.1997.tb16920.x · Cited by 24
Cited by
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Beltran, H., Rickman, D. S., Park, K., Chae, S. S., Sboner, A., MacDonald, T. Y., Wang, Y., Sheikh, K. L., Terry, S., Tagawa, S. T., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0130 · Cited by 999
Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
Epstein, J. I., Amin, M. B., Beltran, H., Lotan, T. L., Mosquera, J.-M., Reuter, V. E., Robinson, B. D., Troncoso, P., & Rubin, M. A. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000208 · Cited by 569
PC3 is a cell line characteristic of prostatic small cell carcinoma
Tai, S., Sun, Y., Squires, J. M., Zhang, H., Oh, W. K., Liang, C., & Huang, J. (2011) · The Prostate · doi:10.1002/pros.21383 · Cited by 438
A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra
Henry, G. H., Malewska, A., Joseph, D. B., Malladi, V. S., Lee, J., Torrealba, J., Mauck, R. J., Gahan, J. C., Raj, G. V., Roehrborn, C. G., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.086 · Cited by 355
Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
Dong, B., Miao, J., Wang, Y., Luo, W., Ji, Z., Lai, H., Zhang, M., Cheng, X., Wang, J., Fang, Y., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01476-1 · Cited by 218
Metadata
- Authors
- Vashchenko, N., & Abrahamsson, P.-A.
- Venue
- European Urology
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 47
- Issue
- 2
- Pages
- 147-155
- ISSN
- 0302-2838 (ISSN-L)
- OpenAlex
- W1972383646
- Cited by
- 260
- References
- 46
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.